Trial Profile
A phase I trial of AZD 1419 in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Nov 2017
Price :
$35
*
At a glance
- Drugs AZD 1419 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 14 Nov 2017 Results published in the Clinical Pharmacology and Therapeutics
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society
- 19 Jan 2016 Results published in Dynavax media release.